DK1117383T3 - Doseringsformer omfattende terapeutisk formulering - Google Patents

Doseringsformer omfattende terapeutisk formulering

Info

Publication number
DK1117383T3
DK1117383T3 DK99948122T DK99948122T DK1117383T3 DK 1117383 T3 DK1117383 T3 DK 1117383T3 DK 99948122 T DK99948122 T DK 99948122T DK 99948122 T DK99948122 T DK 99948122T DK 1117383 T3 DK1117383 T3 DK 1117383T3
Authority
DK
Denmark
Prior art keywords
dosage forms
therapeutic formulation
dosage form
drug formulation
capsule
Prior art date
Application number
DK99948122T
Other languages
Danish (da)
English (en)
Inventor
Liang C Dong
Patrick S-L Wong
Vincent J Ferrari
Steven D Espinal
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK1117383T3 publication Critical patent/DK1117383T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99948122T 1998-09-08 1999-09-03 Doseringsformer omfattende terapeutisk formulering DK1117383T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9940198P 1998-09-08 1998-09-08

Publications (1)

Publication Number Publication Date
DK1117383T3 true DK1117383T3 (da) 2006-04-03

Family

ID=22274837

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99948122T DK1117383T3 (da) 1998-09-08 1999-09-03 Doseringsformer omfattende terapeutisk formulering

Country Status (10)

Country Link
US (5) US6551613B1 (el)
EP (1) EP1117383B1 (el)
JP (1) JP2002524151A (el)
AT (1) ATE310508T1 (el)
AU (1) AU6136199A (el)
CY (1) CY1105388T1 (el)
DE (1) DE69928554T2 (el)
DK (1) DK1117383T3 (el)
ES (1) ES2249915T3 (el)
WO (1) WO2000013674A1 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
EP1239840B1 (en) * 1999-12-09 2005-04-06 Alza Corporation Antiviral medication
KR20080011353A (ko) 2000-02-24 2008-02-01 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
MXPA03000073A (es) 2000-06-26 2003-09-25 Monsanto Technology Llc Formulaciones que contienen agente tensioactivo no acuoso para la liberacion prolongada de somatrotopina.
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
US20030198619A1 (en) * 2001-12-19 2003-10-23 Dong Liang C. Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
NZ537492A (en) * 2002-06-28 2007-10-26 Alza Corp Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1556000A1 (en) * 2002-10-31 2005-07-27 Alza Corporation Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
AU2004261277A1 (en) * 2003-07-31 2005-02-10 Alza Corporation Permeation-Resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
US20050186273A1 (en) * 2003-09-26 2005-08-25 Si-Hong Yum Controlled release dosage form including a banded engine
MXPA06005462A (es) * 2003-11-14 2006-12-15 Johnson & Johnson Liberacion controlada de topiramato en formas de dosificacion liquida.
CA2575396C (en) * 2004-07-30 2012-11-13 Wakunaga Pharmaceutical Co., Ltd. Composition for capsule coating, capsule coating, and capsule using the same
WO2006081569A2 (en) * 2005-01-27 2006-08-03 Alza Corporation Oral osmotic dosage form having a high flux membrane
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
KR20080005429A (ko) * 2005-04-19 2008-01-11 알자 코포레이션 트라마돌 및 가바펜틴을 포함하는 물질의 배합물
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
CN102274557B (zh) 2006-08-09 2014-12-03 精达制药公司 渗透性递送系统和活塞组件
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8764702B2 (en) * 2007-07-05 2014-07-01 Baxter International Inc. Dialysis system having dual patient line connection and prime
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
EP2145643A1 (de) * 2008-07-19 2010-01-20 Markus Storz Portioniertes Arzneimittel
WO2011021594A1 (ja) * 2009-08-18 2011-02-24 国立大学法人東北大学 持続性ドラッグデリバリーシステム
AU2010298733B2 (en) 2009-09-28 2014-10-09 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
PE20121707A1 (es) 2009-12-21 2012-12-17 Ambrx Inc Polipeptidos de somatotropina bovina modificados y sus usos
CN102666578A (zh) 2009-12-21 2012-09-12 Ambrx公司 经过修饰的猪促生长素多肽和其用途
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US20140302021A1 (en) 2011-10-25 2014-10-09 Onclave Therapeutics Limited Antibody formulations and methods
US9199044B2 (en) 2012-08-06 2015-12-01 Elwha Llc Devices and methods for wearable injection guides
US10046119B2 (en) 2012-10-30 2018-08-14 Elwha Llc Systems and methods for generating an injection guide
US9629963B2 (en) 2012-10-30 2017-04-25 Elwha Llc Systems and methods for generating an injection guide
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CA2987766A1 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
SG10201913699QA (en) 2016-05-16 2020-03-30 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US10835580B2 (en) 2017-01-03 2020-11-17 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN111251521B (zh) * 2018-12-03 2022-07-22 沈欣 液态珠丸的制造方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (el) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3905360A (en) 1971-11-01 1975-09-16 Alza Corp Intrauterine device for governing the reproductive process
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111201A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4259323A (en) 1980-03-24 1981-03-31 Hoffmann-La Roche Inc. Potassium chloride emulsion
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
JPS60186385A (ja) 1984-01-30 1985-09-21 不二輸送機工業株式会社 ロボツトハンドの微少移動装置
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4717718A (en) * 1985-08-09 1988-01-05 Alza Corporation Device for the controlled delivery of a beneficial agent
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US5236689A (en) * 1987-06-25 1993-08-17 Alza Corporation Multi-unit delivery system
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US6200600B1 (en) * 1989-02-16 2001-03-13 Btg International Limited Controlled delay release device
US4951494A (en) 1989-10-10 1990-08-28 Alterio Joseph C D Compression rollers with movable shoulder shields
US5213809A (en) * 1990-01-24 1993-05-25 Alza Corporation Delivery system comprising means for controlling internal pressure
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5209746A (en) * 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
EP0621032B1 (en) * 1993-04-23 2000-08-09 Novartis AG Controlled release drug delivery device
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5633011A (en) 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5614578A (en) 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
US5965160A (en) * 1995-04-24 1999-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
AU719085B2 (en) * 1996-08-22 2000-05-04 Rtp Pharma Corporation Processes of preparing or stabilising microparticles
FR2765608B1 (fr) * 1997-07-04 1999-09-10 Manuf Stephanoise De Transform Dispositif connecteur d'arceaux de tente
US6087353A (en) * 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US6445783B1 (en) * 1998-07-14 2002-09-03 At&T Corp. System and method that provides specialized processing of communications based on automatically generated identifiers
US6183466B1 (en) * 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
KR100910604B1 (ko) * 2003-09-26 2009-08-03 디즈니엔터프라이지즈,인크. 휴대폰 페어렌탈 컨트롤
US20060293057A1 (en) * 2005-06-24 2006-12-28 Mazerski Thomas M System and method for secure web-based mobile phone parental controls
US20080046930A1 (en) * 2006-08-17 2008-02-21 Bellsouth Intellectual Property Corporation Apparatus, Methods and Computer Program Products for Audience-Adaptive Control of Content Presentation
US7996005B2 (en) * 2007-01-17 2011-08-09 Eagency, Inc. Mobile communication device monitoring systems and methods
EP2044943A1 (en) * 2007-10-04 2009-04-08 Solvay Pharmaceuticals, Inc. Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same

Also Published As

Publication number Publication date
JP2002524151A (ja) 2002-08-06
US20030157163A1 (en) 2003-08-21
ES2249915T3 (es) 2006-04-01
AU6136199A (en) 2000-03-27
US6551613B1 (en) 2003-04-22
US20100159002A1 (en) 2010-06-24
WO2000013674A1 (en) 2000-03-16
EP1117383A1 (en) 2001-07-25
US20080181944A1 (en) 2008-07-31
US20090130204A1 (en) 2009-05-21
ATE310508T1 (de) 2005-12-15
EP1117383B1 (en) 2005-11-23
DE69928554T2 (de) 2006-03-30
DE69928554D1 (de) 2005-12-29
CY1105388T1 (el) 2010-04-28

Similar Documents

Publication Publication Date Title
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
HK1031197A1 (en) Osmotic dosage form comprising first and second coats
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
NO971206D0 (no) Forlenget-frigjöringsformulering
CY1112260T1 (el) Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
BR0015188A (pt) Composições farmacêuticas
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
ES2099275T3 (es) Comprimido multiparticulas de desleimiento rapido.
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
DK1007006T3 (da) Formulering af cefadroxilmonohydrattablet
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
GR20010100377A (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
NO975634L (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
GEP20043377B (en) Pharmaceutical Complex
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
BG94934A (bg) Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество